| MolName | (E)-N-[[[2-(5-morpholin-4-yltetrazol-2-yl)acetyl]amino]carbamothioyl]-3-thiophen-2-ylprop-2-enamide |
| MolecularFormula | C15H18N8O3S2 |
| Smiles | O=C(Cn1nnc(N2CCOCC2)n1)NNC(NC(/C=C/c1cccs1)=O)=S |
| InChI | InChI=1S/C15H18N8O3S2/c24-12(4-3-11-2-1-9-28-11)16-15(27)19-17-13(25)10-23-20-14(18-21-23)22-5-7-26-8-6-22/h1-4,9H,5-8,10H2,(H,17,25)(H2,16,19,24,27) |
| InChIK | CKXZRVZGZAZWSZ-UHFFFAOYSA-N |
| TotalMolweight | 422.493 |
| Molweight | 422.493 |
| MonoisotopicMass | 422.094327 |
| CLogP | -0.2974 |
| CLogS | -2.532 |
| H Acceptors | 11 |
| H Donors | 3 |
| TotalSurfaceArea | 319.13 |
| Relative PSA | 0.5081 |
| PolarSurfaceArea | 186.63 |
| Druglikeness | 0.6844 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | thio-amide/urea |
| Shape Index | 0.67857 |
| Fragments | 1 |
| Non HAtoms | 28 |
| NonCHAtoms | 13 |
| Electronegative Atoms | 13 |
| Rotatable Bond | 6 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 10 |
| Sp3Atoms | 7 |
| Symmetricatoms | 2 |
| Amides | 1 |
| Aromatic Nitrogens | 4 |
| StereoCon |
Click to Load Molecule:
1 - (E)-N-[[[2-(5-morpholin-4-yltetrazol-2-yl)acetyl]amino]carbamothioyl]-3-thiophen-2-ylprop-2-enamide | 2 - (E)-N-[[[2-(5-morpholin-4-yltetrazol-2-yl)acetyl]amino]carbamothioyl]-3-thiophen-2-ylprop-2-enamide